Concepedia

Angela James

AJ

7

Publications

185

Citations

7

H-Index

2013

Active since

Affiliations

University of Pennsylvania(Current)

Astellas Pharma (United States)

Northwestern University

University of California, Los Angeles

Johns Hopkins University

Angela James is an author at University of Pennsylvania specializing in cancer research, radiation oncology, and molecular oncology.

ORCID

Top concepts

Publications per year

2013–2023

7

Publications

7

Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor

Angela James, Catherine C. Smith, Mark R. Litzow et al. · Clinical Pharmacokinetics · 2020 · 67 citations · Full text

Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML

Keith W. Pratz, Mohamad Cherry, Jessica K. Altman et al. · Journal of Clinical Oncology · 2023 · 40 citations · Full text

A Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML: Final Results

Keith W. Pratz, Mohamad Cherry, Jessica K. Altman et al. · Blood · 2020 · 28 citations

Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid tumors.

Andréa Varga, Monica Mita, Jennifer Wu et al. · Journal of Clinical Oncology · 2013 · 18 citations

, , +14

CC-122 Degrades the Lymphoid Transcription Factor Aiolos (IKZF3) By Modulating Cereblon and Shows Clinical Activity in a Phase Ib Study of Subjects with Relapsed or Refractory Non-Hodgkin’s Lymphoma and Multiple Myeloma

Vincent Ribrag, Silvia Damien, Mecide Gharibo et al. · Blood · 2014 · 11 citations

Rows per page

1–5 of 7